Beyond Air Inc.

Beyond Air Inc. is a biotechnology company focused on developing innovative medical devices and therapies for respiratory conditions. The primary purpose of the company is to advance treatments that utilize nitric oxide to address a range of ailments, notably in the respiratory sector. Beyond Air Inc. is pioneering ground-breaking delivery systems intended to administer nitric oxide directly to patients’ lungs, highlighting a potential shift in traditional respiratory care methods. Operating within the broader healthcare and medical technology industry, the company’s developments have the potential to significantly impact sectors such as pharmaceuticals, biotech research, and medical device manufacturing. Beyond Air Inc. plays a crucial role in fostering advancements in respiratory health care solutions, particularly addressing diseases like chronic obstructive pulmonary disease (COPD) and bronchiolitis. Headquartered in Garden City, New York, the firm serves as an exemplar of integrating cutting-edge science with practical medical applications, spearheading the charge toward more effective, non-invasive treatment modalities.